Detalles de la búsqueda
1.
A phase 1 trial of 8-chloro-adenosine in relapsed/refractory acute myeloid leukemia: An evaluation of safety and pharmacokinetics.
Cancer
; 130(5): 727-739, 2024 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37897709
2.
Randomized placebo-controlled, double-blind clinical trial of nanoemulsion curcumin in women with aromatase inhibitor-induced arthropathy: an Alliance/NCORP pilot trial.
Breast Cancer Res Treat
; 205(1): 61-73, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38280052
3.
Response-adapted anti-PD-1-based salvage therapy for Hodgkin lymphoma with nivolumab alone or in combination with ICE.
Blood
; 139(25): 3605-3616, 2022 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-35316328
4.
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Am J Hematol
; 2024 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38804599
5.
A Practical Guide to Relugolix: Early Experience With Oral Androgen Deprivation Therapy.
Oncologist
; 28(8): 699-705, 2023 08 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36888587
6.
Long-Term Outcomes of Allogeneic Hematopoietic Cell Transplant with Fludarabine and Melphalan Conditioning and Tacrolimus/Sirolimus as Graft-versus-Host Disease Prophylaxis in Patients with Acute Lymphoblastic Leukemia.
Biol Blood Marrow Transplant
; 26(8): 1425-1432, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32416253
7.
Therapy-related acute lymphoblastic leukemia has distinct clinical and cytogenetic features compared to de novo acute lymphoblastic leukemia, but outcomes are comparable in transplanted patients.
Haematologica
; 103(10): 1662-1668, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29903756
8.
Phase II Study of Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BCNU, Etoposide, Cytarabine, and Melphalan for Non-Hodgkin Lymphoma: The Role of Histology.
Biol Blood Marrow Transplant
; 23(6): 922-929, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28267593
9.
Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Chemotherapy in Mantle Cell Lymphoma Patients Is Associated with Higher Rates of Hematopoietic Progenitor Cell Mobilization Failure despite Plerixafor Rescue.
Biol Blood Marrow Transplant
; 23(8): 1264-1268, 2017 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-28434928
10.
Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia.
Biol Blood Marrow Transplant
; 23(4): 618-624, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-28087456
11.
Venetoclax and hypomethylating agents yield high response rates and favourable transplant outcomes in patients with newly diagnosed acute myeloid leukaemia.
Br J Haematol
; 196(6): e71-e74, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34931310
12.
Engraftment and outcomes following autologous stem cell transplantation in Hodgkin lymphoma patients mobilized with plerixafor.
Hematol Oncol
; 35(3): 281-287, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26928577
13.
Cytogenetics Does Not Impact Outcomes in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 22(7): 1212-1217, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27044907
14.
Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 22(2): 268-276, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26325438
15.
Brentuximab vedotin is associated with improved progression-free survival after allogeneic transplantation for Hodgkin lymphoma.
Biol Blood Marrow Transplant
; 20(11): 1864-8, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-25008328
16.
Autologous transplantation for transformed non-Hodgkin lymphoma using an yttrium-90 ibritumomab tiuxetan conditioning regimen.
Biol Blood Marrow Transplant
; 20(12): 2072-5, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25079874
17.
Brentuximab vedotin enables successful reduced-intensity allogeneic hematopoietic cell transplantation in patients with relapsed or refractory Hodgkin lymphoma.
Blood
; 119(26): 6379-81, 2012 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-22611160
18.
Brentuximab Vedotin Plus Ibrutinib in Relapsed and Refractory Hodgkin Lymphoma.
Clin Lymphoma Myeloma Leuk
; 2024 Apr 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38693037
19.
Yttrium-90 Anti-CD25-BEAM-Conditioning for Autologous Hematopoietic Cell Transplantation in Peripheral T Cell Lymphoma.
Blood Adv
; 2024 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-38838232
20.
Post-Transplantation Sinusoidal Obstruction Syndrome in Adult Patients with B Cell Acute Lymphoblastic Leukemia Treated with Pretransplantation Inotuzumab.
Transplant Cell Ther
; 29(5): 314-320, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36682470